Q32 Bio Set to Present at March Investor Conferences Featuring Its Immune Restoring Therapeutics Q32 Bio will present at two major investor conferences in March 2025, focusing on their breakthrough research in immune restoration therapies.

Q32 Bio Set to Present at March Investor Conferences Featuring Its Immune Restoring Therapeutics #USA #Q32_Bio #Bempikibart #immune_therapy #Waltham,_MA